TherapeuticsMD (TXMD) Return on Equity [ROE] (2013 - 2026)
TherapeuticsMD (TXMD) reported Return on Equity [ROE] of -0.80% for Q2 2026, up 0.90 percentage points from -1.70% a year earlier but down 1.47 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, TherapeuticsMD posted Return on Equity [ROE] of -2.10%, up 5.60 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at -7.70% in FY2024 (+24.21 pp) and -31.90% in FY2023.
- Five-year quarterly Return on Equity [ROE] spans a low of -35.85% in Q4 2023 and a high of 468.73% in Q1 2023.
- Year over year, Return on Equity [ROE] has now increased in each of the last seven quarters, with an average year-over-year change of -18.59 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 27.84 percentage points); the low point was Q1 2024 (a drop of 494.30 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.66% (Q1 2026), -2.09% (Q4 2025) and 1.10% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.17 Bn | 1,101.76 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 634.79 Bn | 554.65 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 506.40 Bn | 479.51 Bn | 12.70 Bn | - |
| 4 | Merck | 357.93 Bn | 312.31 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.69 Bn | 256.68 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.19 Bn | 238.87 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 238.22 Bn | 193.61 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.23 Bn | 169.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 4.97% |
| 10 | TherapeuticsMD | 21.12 Mn | 21.12 Mn | - | -0.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.80% |
| Mar 31, 2026 | 0.66% |
| Dec 31, 2025 | -2.09% |
| Sep 30, 2025 | 1.10% |
| Jun 30, 2025 | -1.70% |
| Mar 31, 2025 | -7.76% |
| Dec 31, 2024 | -8.01% |
| Sep 30, 2024 | -12.11% |
| Jun 30, 2024 | -21.60% |
| Mar 31, 2024 | -25.57% |
| Dec 31, 2023 | -35.85% |
| Sep 30, 2023 | 230.58% |
| Jun 30, 2023 | 135.14% |
| Mar 31, 2023 | 468.73% |
| Jun 30, 2019 | -493.52% |
| Mar 31, 2019 | -186.73% |
| Dec 31, 2018 | -114.45% |
| Sep 30, 2018 | -108.29% |
| Jun 30, 2018 | -101.39% |
| Mar 31, 2018 | -67.59% |
API Access
TherapeuticsMD Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();